Aprea Therapeutics, Inc. (APRE)
0.695
-0.03
(-3.94%)
USD |
NASDAQ |
Oct 02, 16:00
0.6951
0.00 (0.00%)
After-Hours: 20:00
Aprea Therapeutics Price : 0.695 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 0.716 | 0.7362 | 0.685 | 0.695 | 862295.0 |
| Oct 01, 2026 | 0.7635 | 0.7815 | 0.675 | 0.7235 | 779689.0 |
| Sep 30, 2026 | 0.78 | 0.82 | 0.7405 | 0.75 | 582211.0 |
| Sep 29, 2026 | 0.7579 | 0.8200 | 0.75 | 0.7696 | 591615.0 |
| Sep 28, 2026 | 0.76 | 0.7711 | 0.7402 | 0.7518 | 69811.00 |
| Sep 25, 2026 | 0.78 | 0.7803 | 0.7414 | 0.7608 | 53344.00 |
| Sep 24, 2026 | 0.80 | 0.80 | 0.7651 | 0.7797 | 52252.00 |
| Sep 23, 2026 | 0.7424 | 0.81 | 0.7424 | 0.78 | 282116.0 |
| Sep 22, 2026 | 0.76 | 0.76 | 0.7001 | 0.7324 | 189648.0 |
| Sep 21, 2026 | 0.7599 | 0.7599 | 0.73 | 0.737 | 96747.00 |
| Sep 18, 2026 | 0.78 | 0.78 | 0.74 | 0.7599 | 79988.00 |
| Sep 17, 2026 | 0.75 | 0.772 | 0.73 | 0.75 | 117507.0 |
| Sep 16, 2026 | 0.729 | 0.757 | 0.7111 | 0.7305 | 186002.0 |
| Sep 15, 2026 | 0.82 | 0.82 | 0.7333 | 0.7488 | 184176.0 |
| Sep 14, 2026 | 0.771 | 0.8427 | 0.76 | 0.7814 | 120274.0 |
| Sep 11, 2026 | 0.7957 | 0.8199 | 0.7651 | 0.7740 | 127716.0 |
| Sep 10, 2026 | 0.7805 | 0.8100 | 0.7805 | 0.7892 | 61330.00 |
| Sep 09, 2026 | 0.85 | 0.871 | 0.7832 | 0.7914 | 135464.0 |
| Sep 08, 2026 | 0.8403 | 0.88 | 0.7788 | 0.835 | 323718.0 |
| Sep 04, 2026 | 0.80 | 0.8092 | 0.7914 | 0.7943 | 90483.00 |
| Sep 03, 2026 | 0.82 | 0.82 | 0.7802 | 0.8063 | 112970.0 |
| Sep 02, 2026 | 0.8101 | 0.854 | 0.7986 | 0.82 | 170563.0 |
| Sep 01, 2026 | 0.78 | 0.90 | 0.7795 | 0.8357 | 465706.0 |
| Aug 31, 2026 | 0.8454 | 0.8517 | 0.78 | 0.80 | 479834.0 |
| Aug 28, 2026 | 0.88 | 0.9099 | 0.8202 | 0.8386 | 346178.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Zymeworks, Inc. | 25.15 |
| Rhythm Pharmaceuticals, Inc. | 92.83 |
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Savara, Inc. | 4.81 |
Price Related Metrics
| PS Ratio | 2747.58 |
| Price to Book Value | 0.2239 |
| Earnings Yield | -154.9% |
| Market Cap | 8.612M |